Literature DB >> 14586424

Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling.

Jesse E Jun1, Christopher C Goodnow.   

Abstract

Lymphocyte antigen receptors are responsible for inducing the opposite responses of immunity or tolerance. How the correct polarity of antigen receptor signaling is encoded has been an enduring enigma. Here we summarize recent advances defining key scaffolding molecules, CARMA1 (also known as CARD11) and the Cbl family of ubiquitin ligases, required for either immunogenic or tolerogenic signaling by antigen receptors. These scaffolding proteins may determine the polarity of response to antigen by promoting assembly around antigen receptors of competing multiprotein signal complexes: immunosomes versus tolerosomes. Each of the factors that influence immunogenicity or tolerogenicity--stage of lymphocyte differentiation, concurrent engagement of inhibitory or costimulatory receptors, extent of receptor crosslinking, and prior antigen experience--may be integrated in lymphocytes through their capacity to influence the probability of assembling immunosomes versus tolerosomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586424     DOI: 10.1038/ni1001

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  31 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

2.  A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.

Authors:  Shuling Guo; Gregory Z Ferl; Rajendar Deora; Mireille Riedinger; Sheng Yin; James L Kerwin; Joseph A Loo; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

Review 3.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

4.  B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins.

Authors:  Jannek Hauser; Natalia Sveshnikova; Anders Wallenius; Sanna Baradaran; Juha Saarikettu; Thomas Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-18       Impact factor: 11.205

Review 5.  Molecular characterization of human plasmacytoid dendritic cells.

Authors:  Wei Cao
Journal:  J Clin Immunol       Date:  2009-03-06       Impact factor: 8.317

Review 6.  Molecular basis of lysophosphatidic acid-induced NF-κB activation.

Authors:  Wenjing Sun; Jianhua Yang
Journal:  Cell Signal       Date:  2010-05-12       Impact factor: 4.315

7.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors:  Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

8.  Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis.

Authors:  Brittany L Hartwell; Chad J Pickens; Martin Leon; Cory Berkland
Journal:  Biomacromolecules       Date:  2017-05-17       Impact factor: 6.988

Review 9.  Regulation of autoreactive B cell responses to endogenous TLR ligands.

Authors:  Ana Maria Avalos; Liliana Busconi; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

10.  Modulation of peripheral B cell tolerance by CD72 in a murine model.

Authors:  Daniel Hsieh-Hsin Li; Monte M Winslow; Thai M Cao; Albert H Chen; Corrine R Davis; Elizabeth D Mellins; Paul J Utz; Gerald R Crabtree; Jane R Parnes
Journal:  Arthritis Rheum       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.